MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AKTIPIS, S.
Right arrow Articles by PANAYOTATOS, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AKTIPIS, S.
Right arrow Articles by PANAYOTATOS, N.

Molecular Pharmacology, Vol 13, 706-718, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

The Inhibitory Effect of Phenanthridines on the Synthesis of Ribonucleic Acid Catalyzed by Deoxyribonucleic Acid-Dependent Ribonucleic Acid Polymerase

STELIOS AKTIPIS 1 and NIKOS PANAYOTATOS 1

1 Department of Biochemistry and Biophysics, Stritch School of Medicine, Loyola University of Chicago, Maywood, Illinois 60153

The interaction of RNA polymerase with DNA prior to the initiation of RNA synthesis involves the formation of a specific complex (I) which is in equilibrium with a rapidly starting (RS) complex necessary for the rapid initiation of RNA chains. Phenanthridinium derivatives, including ethidium bromide, are effective inhibitors of RNA synthesis. These inhibitors do not affect either the rate of transformation of the I complex to the RS complex or the rate of transformation of the RS complex to the initiation complex. Phenanthridines, which intercalate into the DNA template and modify its conformation, act instead by limiting the number of enzyme molecules which can recognize and interact productively with the promoter regions of the template to form I complexes. This explanation is also consistent with the observed variation of the effectiveness of various phenanthridinium derivatives as inhibitors of RNA polymerase. Derivatives with a bulky phenyl group at C-6 of the phenanthridinium ring are decidedly better inhibitors of the enzyme than derivatives which carry a small aliphatic group in the same position.

Note:
ACKNOWLEDGMENTS We are indebted to Dr. T. I. Watkins for his kind cooperation and his generous gift of a number of phenanthridinium derivatives.

Submitted on November 16, 1976
Accepted on February 10, 1977







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics